Common use of Development Candidate Clause in Contracts

Development Candidate. A Development Candidate shall have been ---------------------------- deemed to have been nominated upon the earlier of the date (i) the Schering- Plough Research Institute Project Assessment Committee or its successor approves proceeding with full development of such compound, or (ii) SPL (or its Affiliate) initiates in vivo toxicology trials necessary, and meeting U.S. FDA (or corresponding European or Japanese) standards, for obtaining approval for use of such Agreement Compound in human clinical trials. Within thirty (30) days after the nomination of a Development Candidate, SPL shall notify Pharmacopeia thereof, which notification will include identification of the applicable Target(s) (in coded form only) and the general therapeutic area relevant to such Target

Appears in 1 contract

Sources: Collaboration and License Agreement (Pharmacopeia Inc)

Development Candidate. A Development Candidate shall have been ---------------------------- deemed to have been nominated upon the earlier of the date (i) the Schering- Plough Research Institute Project Assessment Committee or its successor approves proceeding with full development of such compound, or (ii) SPL Schering (or its Affiliate) initiates in vivo toxicology trials necessary, and meeting U.S. FDA ------- (or corresponding European or Japanese) standards, for obtaining approval for use of such Agreement Compound in human clinical trials. Within thirty (30) days after the nomination of a Development Candidate, SPL Schering shall notify Pharmacopeia thereof, which notification will include identification of the applicable Target(s) (in coded form only) and the general therapeutic area relevant to such Target.

Appears in 1 contract

Sources: Collaboration and License Agreement (Pharmacopeia Inc)